Knockdown of PTOV1 and PIN1 Exhibit Common Phenotypic Anti-cancer Effects in MDA-MB-231 Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 May 15

PMID 31083670

Citations 8

Authors

Shibendra Kumar Lal Karna

Faiz Ahmad

Bilal Ahmad Lone

Yuba Raj Pokharel

Affiliations

Soon will be listed here.

Abstract

Background: Earlier, we have identified PTOV1 as a novel interactome of PIN1 in PC-3 cells. This study aims to explore the functional similarity and the common role of both genes in breast cancer cell proliferation.

Methods: CTG, crystal violet assay, clonogenic assay, wound healing assay, cell cycle analysis, Hoechst staining and ROS measurement were performed to assess cell viability, colony forming potential, cell cycle arrest, nuclear condensation and ROS production after knocking down of PTOV1 and PIN1 by siRNAs in MDA-MB-231 and MCF-7 cells. CO-IP, qPCR and western blot were performedto study interaction, transcriptional and translational regulation of both genes.

Results: Knockdown of PTOV1 and PIN1 inhibited the cell proliferation, colony formation, migration, cell cycle, and induced nuclear condensation as well as ROS production. Interaction of PTOV1 and PIN1 was validated by Co-IP in MDA-MB-231 cells. Genes involved in cell proliferation, migration, cell cycle, and apoptosis were regulated by PIN1 and PTOV1. PTOV1 knockdown inhibited Bcl-2, Bcl-xL and inducedBAX, LC3 and Beclin-1expression. Overexpression of PIN1 increased the expression of PTOV1. Knockdown of both genes inhibited the expression of cyclin D1, c-Myc, and β-catenin.

Conclusions: PTOV1 and PIN1 interact and exert oncogenic role in MDA-MB-231 cells by sharing the similar expression profile at transcriptional and translational level which can be a promising hub for therapeutic target.

Citing Articles

PTOV1 facilitates colorectal cancer cell proliferation through activating AKT1 signaling pathway.

Xie S, Zhang W, Du F, Liu S, Ning T, Zhang N Heliyon. 2024; 10(16):e36017.

PMID: 39229496 PMC: 11369455. DOI: 10.1016/j.heliyon.2024.e36017.

Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities.

Gurung D, Danielson J, Tasnim A, Zhang J, Zou Y, Liu J Biology (Basel). 2023; 12(7).

PMID: 37508437 PMC: 10376262. DOI: 10.3390/biology12071008.

Synergistic Effects of AgNPs and Biochar: A Potential Combination for Combating Lung Cancer and Pathogenic Bacteria.

Abu Hajleh M, Al-Limoun M, Al-Tarawneh A, Hijazin T, Alqaraleh M, Khleifat K Molecules. 2023; 28(12).

PMID: 37375312 PMC: 10303427. DOI: 10.3390/molecules28124757.

Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cells.

Hancock G, Young K, Hosfield D, Joiner C, Sullivan E, Yildiz Y NPJ Breast Cancer. 2022; 8(1):130.

PMID: 36517522 PMC: 9748900. DOI: 10.1038/s41523-022-00497-9.

Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway.

Kong L, Liu X, Yu B, Yuan Y, Zhao Q, Chen Y Front Pharmacol. 2022; 13:797873.

PMID: 35450041 PMC: 9016199. DOI: 10.3389/fphar.2022.797873.

References

Wu L, Timmers C, Maiti B, Saavedra H, Sang L, Chong G . The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001; 414(6862):457-62. DOI: 10.1038/35106593. View

Sengupta J, Nilsson J, Gursky R, Spahn C, Nissen P, Frank J . Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM. Nat Struct Mol Biol. 2004; 11(10):957-62. DOI: 10.1038/nsmb822. View

Lu Z, Hunter T . Prolyl isomerase Pin1 in cancer. Cell Res. 2014; 24(9):1033-49. PMC: 4152735. DOI: 10.1038/cr.2014.109. View

Gump J, Thorburn A . Autophagy and apoptosis: what is the connection?. Trends Cell Biol. 2011; 21(7):387-92. PMC: 3539742. DOI: 10.1016/j.tcb.2011.03.007. View

Coyle S, Gilbert W, Doudna J . Direct link between RACK1 function and localization at the ribosome in vivo. Mol Cell Biol. 2008; 29(6):1626-34. PMC: 2648249. DOI: 10.1128/MCB.01718-08. View

Zardawi S, OToole S, Sutherland R, Musgrove E . Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol. 2009; 24(3):385-98. DOI: 10.14670/HH-24.385. View

Yang R, Muller C, Huynh V, Fung Y, Yee A, Koeffler H . Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol Cell Biol. 1999; 19(3):2400-7. PMC: 84032. DOI: 10.1128/MCB.19.3.2400. View

Rodriguez L, Wu X, Guan J . Wound-healing assay. Methods Mol Biol. 2004; 294:23-9. DOI: 10.1385/1-59259-860-9:023. View

Yeh E, Means A . PIN1, the cell cycle and cancer. Nat Rev Cancer. 2007; 7(5):381-8. DOI: 10.1038/nrc2107. View

10.

Kawamoto H, Koizumi H, Uchikoshi T . Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. Am J Pathol. 1997; 150(1):15-23. PMC: 1858517. View

11.

Crowley L, Marfell B, Waterhouse N . Analyzing Cell Death by Nuclear Staining with Hoechst 33342. Cold Spring Harb Protoc. 2016; 2016(9). DOI: 10.1101/pdb.prot087205. View

12.

Tamm I, Schriever F, Dorken B . Apoptosis: implications of basic research for clinical oncology. Lancet Oncol. 2002; 2(1):33-42. DOI: 10.1016/S1470-2045(00)00193-5. View

13.

Karimian A, Ahmadi Y, Yousefi B . Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016; 42:63-71. DOI: 10.1016/j.dnarep.2016.04.008. View

14.

Ghoncheh M, Pournamdar Z, Salehiniya H . Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev. 2016; 17(S3):43-6. DOI: 10.7314/apjcp.2016.17.s3.43. View

15.

Ravdin P, Cronin K, Howlader N, Berg C, Chlebowski R, Feuer E . The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007; 356(16):1670-4. DOI: 10.1056/NEJMsr070105. View

16.

Wulf G, Ryo A, Wulf G, Lee S, Niu T, Petkova V . Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001; 20(13):3459-72. PMC: 125530. DOI: 10.1093/emboj/20.13.3459. View

17.

Elbendary A, Cirisano F, Evans Jr A, DAVIS P, Iglehart J, Marks J . Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res. 1996; 2(9):1571-5. View

18.

Reed J . Dysregulation of apoptosis in cancer. J Clin Oncol. 1999; 17(9):2941-53. DOI: 10.1200/JCO.1999.17.9.2941. View

19.

Li J, Xie D . RACK1, a versatile hub in cancer. Oncogene. 2014; 34(15):1890-8. DOI: 10.1038/onc.2014.127. View

20.

Marques N, Sese M, Canovas V, Valente F, Bermudo R, de Torres I . Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1. Oncogene. 2013; 33(9):1124-34. DOI: 10.1038/onc.2013.51. View